Identification of Immunogenic Neo-epitopes for the Development of Personalised Pancreatic Cancer Vaccines

Clinical trial NCT04379960 · COMPLETED

Trial details

NCT number: NCT04379960
Sponsor: Queen Mary University of London
Status: COMPLETED
Study type: OBSERVATIONAL

The Initial Aim of This Project is to Perform in Vitro Validation of Neoepitope Candidates Selected From Available Mutanome Data

Start date: 2016-09-01
Primary completion: 2021-10-01
Enrollment: 192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.